Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC

Autor: Rolfo, Christian, Greillier, Laurent, Veillon, Remi, Badin, Firas, Ghiringhelli, Francois, Isambert, Nicolas, Paulus, Astrid, Chaudhary, Surendra Pal, Vugmeyster, Yulia, Sato, Masashi, Hiret, Sandrine
Zdroj: In JTO Clinical and Research Reports October 2024
Databáze: ScienceDirect